Bharat Biotech vaccine

The country's first Nasal Corona vaccine launches on Republic Day

Nasal Covid-19 Vaccine: The first intranasal Covid-19 vaccine 'Incovac' developed in the country will be started from January 26. It has been made by Swadeshi Bharat Biotech.

Jan 22, 2023, 10:32 AM IST

PT1M4S

DCGI approves Corona's Nasal Vaccine

Another vaccine has been approved in the war against the corona epidemic. DCGI has approved Bharat Biotech's nasal vaccine for Corona. This will be the country's first nasal vaccine.

Sep 06, 2022, 16:54 PM IST

AIIMS Delhi to start second dose trial of Bharat Biotech’s Covaxin on 2-6 years old children by next week

As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week.

Jul 23, 2021, 06:33 AM IST

COVID-19: Bharat Biotech ready for Covaxin's clinical trial in US

The full data from studies on Covaxin's neutralisation of variants are already published.

Jun 12, 2021, 22:39 PM IST

People with THESE health conditions will get COVID-19 vaccine jabs on priority, check full list

In the third phase of the coronavirus vaccination drive which begins from March 1, the government is aiming to expand the vaccination drive to the general public of the nation, which include people with co-morbidities in the 45-59 years age group and senior citizens.

Feb 27, 2021, 22:54 PM IST

For COVID-19 vaccine in private hospital this is how much you may have to pay

The proposed price range was decided in a meeting between Dr. VK Paul, NITI Aayog and representatives from Serum Institute of India and Bharat Biotech. However, the final call on the price range will be taken by the Union health Ministry.

Feb 27, 2021, 18:05 PM IST

COVID-19 vaccine price between Rs 300-500, proposes NITI Aayog

The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities in the third phase of vaccination set to begin from March 1, sources privy to the development revealed, adding that the Bharat Biotech’s Covaxin would cost a bit higher.

Feb 27, 2021, 16:51 PM IST

COVID-19 vaccine: Bharat Biotech to pay compensation if Covaxin causes side effects

Bharat Biotech, which has received a government purchase order for the supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company will pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

Jan 16, 2021, 15:43 PM IST